HomeProducts › Oncology › Gemsar RTU 1gm Injection

Gemsar RTU 1gm Injection

Salt Composition: GEMCITABINE

₹3657.00₹7312.50

Inclusive of all taxes

Gemsar RTU 1gm Injection

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Gemsar RTU 1gm injection contains gemcitabine and is indicated for the treatment of bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is characterised by uncontrolled and abnormal cell multiplication. Inform your doctor if you have heart disease, liver disorders, kidney disorders, have recently undergone radiotherapy, or have received vaccination prior to commencing this medicine. Gemsar RTU 1gm injection is not recommended for adolescents and children below 18 years of age. Your doctor will monitor your blood cell counts and assess kidney and liver function with each administration of this medicine. Use effective contraception during treatment and for at least six months after the final dose. This injection may impair fertility in male patients. Male patients taking this medicine are advised not to father a child during treatment and for 6 months after completing treatment. Notify your doctor if you follow a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you develop shortness of breath, wheezing, changes in urine colour or volume, bleeding, or upper abdominal pain whilst taking Gemsar RTU 1gm injection.

Uses

Gemsar RTU 1gm injection is used to treat Bladder cancer, in combination with cisplatin Ovarian cancer, in combination with carboplatin Breast cancer, in combination with paclitaxel Pancreatic cancer Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

How it works

Gemsar RTU 1gm injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.

How to Use

Gemsar RTU 1gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Pulmonary toxicity (shortness of breath, wheezing, cough) Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding) Pain or tenderness in the upper abdomen Allergic reactions, rashes, fever, swelling or sores in the mouth Common Nausea, vomiting Low blood cell count Loss of appetite Hair loss Swelling of ankles, feet, and fingers Insomnia Constipation, diarrhea Headache Runny nose, chills Muscle pain, back pain Sweating hair loss liver problems blood in urine abnormal urine test Oedema (swelling of ankles, fingers, feet, face)

Expert Tips

It is not recommended to take Gemsar RTU 1gm injection if you are allergic to Gemcitabine or any of its ingredients. During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications. This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment. Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor. It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.

References

  1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1700.
  2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 870.
  3. Sun Pharmaceutical Industries, Electronic medicines compendium (emc), [ Revised on May 2022] [ Accessed on 20 Mar 2023], https://www.medicines.org.uk/emc/files/pil.7298.pdf
  4. Hospira, Inc, US Food and Drug Administration, [ Revised on June 2019 [ Accessed on 20 Mar 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020509s077lbl.pdf

Safety Advice

Pregnancy: unsafe GeGemsar RTU mibine 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.

Lungs: Consult your doctor Gemsar RTU 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.

Breastfeeding: unsafe You must not breastfeed while being treated with Gemsar RTU 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS